Eagle Pharmaceuticals
EGRX
#10347
Rank
โ‚น0.81 B
Marketcap
โ‚น62.89
Share price
0.00%
Change (1 day)
-12.62%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: โ‚น0.81 Billion

As of December 2025 Eagle Pharmaceuticals has a market cap of โ‚น0.81 Billion. This makes Eagle Pharmaceuticals the world's 10347th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น0.81 B33.28%
2024โ‚น0.61 B-89.19%
2023โ‚น5.65 B-82.04%
2022โ‚น31.48 B-35.68%
2021โ‚น48.94 B10.29%
2020โ‚น44.37 B-24%
2019โ‚น58.39 B48.98%
2018โ‚น39.19 B-22.98%
2017โ‚น50.89 B-39%
2016โ‚น83.43 B-9.44%
2015โ‚น92.13 B568.2%
2014โ‚น13.78 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
โ‚น0.81 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น43.706 T 5,363,386.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น8.778 T 1,077,191.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
โ‚น22.781 T 2,795,559.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
โ‚น2.933 T 359,866.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚น15.958 T 1,958,274.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น81.364 T 9,984,723.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น9.537 T 1,170,304.01%๐Ÿ‡บ๐Ÿ‡ธ USA